Reyes-Myrna C, Torres-Hernández CM, Herrera-Ortíz A, Figueroa-Angel V

Language: Spanish
References: 14
Page: 46-52
PDF size: 2172.65 Kb.

ABSTRACT

Background: Brain tumors are the fifth leading cause of death in women of 20-39 years of age, including pregnant w ith similar onset and evolution.
Case Report: 33 years of age w ith neuro logical manifestations due toan intracranial meningioma and 37 weeks pregnant. The pregnancy was terminated and the tumor was removed; the results were favorable for the mother and child.
Conclusions: The incidence of intracranial tumors during pregnancy is extremely low. Headache is the first symptom in almost 90% of cases, but are also common: nausea, vomiting, seizures and neurological deficits. MRI is the diagnostic study of choice. Meningiomas are the most common benign primary brain tumors of the central nervous system. They are a rare association; pregnant patients often experience more symptoms under accelerated tumor growth of a neoplasm usually slow growing. The treatment is surgical, although the current trend is the conservative treatment to achieve viable pregnancies. Emergency neurosurgery is reserved for cases with suspected increase in ICP, herniation, progressive neurological deterioration or other condition that threatens the life of the mother. The choice between Caesarean delivery and not only neurosurgery, there are multiple obstetrical, neurological and anesthesia to be taken into account factors. The prognosis is generally excellent with a 5-year survival greater than 90%.

REFERENCES

1. Simon RH. Brain tumors in pregnancy. Semin Neurol. 1988; 8:214–221.

2. Michelle S. Chow, Mercier PA, Omahen DA, Ewood SL, Johnson JA. Recurrent Exophytic Meningioma in Pregnancy. Obstet Gynecol 2013; 121: 475-8.

3. Imad, Ashraf, Huda. Management Strategy for Meningioma in Pregnancy: A Clinical Study. Skull Base: An Interdisciplinary approach. Vol. 13 Num. 4. 2003. 197 – 203.

4. Stevenson, Thompson. The Clinical Managment of Intracranial Neoplasms in Pregnancy. Clinical Obstetrics and Gynecology. Vol 48. Num 1. 2005. 24-37.

5. Carroll SR, Glowacka D. Progesterone receptor expression in meningiomas. Cancer Res 1993, 53: 1312-1316.

6. Ojeda Di Ninno. Receptores de progesterona en meningioma. Rev Med Hered 1995.Vol.6.Num.3.

7. Grunberg S. Daniels AM, Muensch H, Daniels JR, Bernsteinl, Kortes V, Weiss MH. Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem cell assay. J Neurosurg 1987; 66: 405-408.

8. Piquer J, Cerda M, Llusch A. Correlations of female steroid receptors with histologic features in meningiomas. Acta Neruochir (Wien) 1991; 110: 38-43.

9. DeAngelis LM. Central nervous system neoplasms in pregnancy. Adv Neurol. 1994; 64:139–152.

10. Keating RF. Brain tumors. In: Cohen WR, ed. Cherry & Merkatz’s Complications of Pregnancy 5th Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:547–533

11. Yust-Katz, Shlomit; de Groot, et.al. Pregnancy and glial brain tumors. Neuro-Oncology. 2014. 16(9):1289-1294

12. S. Greenberg M. Meningiomas. Handbook of Neurosurgery. 7° Edition ed. Tampa, Florida: Thieme; 2010. p. 613-20; 63-64.

13. Lusis EA, Scheithauer BW, Bernd, et.al. Meningiomas resected during pregnancy: a clinicopathologic study of eigth patients. Neuro-Oncology. 12. 2010. IV 78- iv81.

14. Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, et al. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery. 2012; 71:951–961.